Hypertension and Excess Risk for Severe COVID-19 Illness Despite Booster Vaccination

Rapid development of vaccines against SARS-CoV-2 led to substantial reductions in morbidity and mortality early in the pandemic. Concerns regarding waning immunity and the risk of emerging new variants, including Omicron, prompted recommendations for a third booster vaccine dose after completion of a 2-dose mRNA vaccine regimen, given its efficacy at further reducing risk for severe illness by up…

Read the full article here

Related Articles